These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29179767)

  • 1. Rhabdomyolysis, lactic acidosis, and multiple organ failure during telbivudine treatment for hepatitis B: a case report and review of the literature.
    Zheng J; Deng M; Qiu X; Chen Z; Li D; Deng X; Deng Q; Yu Z
    J Med Case Rep; 2017 Nov; 11(1):331. PubMed ID: 29179767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B.
    Ying Y; Hu YK; Jin JL; Zhang JM; Zhang WH; Huang YX
    BMC Gastroenterol; 2018 Apr; 18(1):45. PubMed ID: 29625557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactic acidosis during telbivudine treatment for HBV: a case report and literature review.
    Jin JL; Hu P; Lu JH; Luo SS; Huang XY; Weng XH; Zhang JM
    World J Gastroenterol; 2013 Sep; 19(33):5575-80. PubMed ID: 24023503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telbivudine myopathy in a patient with chronic hepatitis B.
    Wang M; Da Y; Cai H; Lu Y; Wu L; Jia J
    Int J Clin Pharm; 2012 Jun; 34(3):422-5. PubMed ID: 22527478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telbivudine-induced rhabdomyolysis in a patient undergoing haemodialysis: A case report and review of literature.
    Wu K; Xu X; Huang L; Zhu E; Dong Y; Zhang Z; Yan X; Zhang Y
    J Int Med Res; 2023 Dec; 51(12):3000605231222244. PubMed ID: 38140948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment.
    Fung J; Seto WK; Lai CL; Yuen MF
    J Gastroenterol Hepatol; 2014 Mar; 29(3):428-34. PubMed ID: 24372662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous venovenous hemodiafiltration for hyperlactatemia caused by telbivudine in a patient with chronic hepatitis B: a case report and update review.
    Wang YH; Wu BQ; Liu H
    J Dig Dis; 2015 Mar; 16(3):164-7. PubMed ID: 25043654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of telbivudine therapy in liver failure patients with chronic hepatitis B virus infection.
    Wang L; Chen H; Fan C; Gong Z
    J Med Virol; 2013 Nov; 85(11):1907-12. PubMed ID: 23852947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of telbivudine-related fatal lactic acidosis and multiple organ dysfunction syndrome].
    She C; Deng Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Jun; 44(6):714-719. PubMed ID: 31304935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B.
    Kim EH; Park H; Lee KH; Ahn SH; Kim SM; Han KH
    Clin Mol Hepatol; 2013 Mar; 19(1):82-6. PubMed ID: 23593614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match-control study.
    Tsai MC; Chen CH; Hung CH; Lee CM; Chiu KW; Wang JH; Lu SN; Tseng PL; Chang KC; Yen YH; Hu TH
    Clin Microbiol Infect; 2014 Feb; 20(2):O90-O100. PubMed ID: 23659493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the forty-eight week efficacy between telbivudine and entecavir in HBeAg-positive Asian patients with chronic hepatitis B: A meta-analysis.
    Wang N; Hu HD; Sun H; Feng Q; Hu P; Liu Q; Ren H
    Turk J Gastroenterol; 2013; 24(3):230-40. PubMed ID: 24226716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of telbivudine antiviral treatment in patients with hepatitis B virus-associated glomerulonephritis: A 104-week pilot study.
    Yan Z; Qiao B; Zhang H; Wang Y; Gou W
    Medicine (Baltimore); 2018 Aug; 97(31):e11716. PubMed ID: 30075577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of sequential use of telbivudine in hepatitis B e antigen-positive chronic hepatitis B patients with partial responses to pegylated interferon: a pilot study.
    Huang Z; Zhao Z; Zheng Y; Peng L; Lin C; Deng H; Gao Z
    J Viral Hepat; 2013 Apr; 20 Suppl 1():52-7. PubMed ID: 23458525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudine.
    Cai S; Cao J; Yu T; Xia M; Peng J
    Medicine (Baltimore); 2017 Jun; 96(22):e7021. PubMed ID: 28562554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive patients: a prospective cohort study in China.
    Zhang Y; Hu P; Qi X; Ren H; Mao RC; Zhang JM
    Clin Microbiol Infect; 2016 Mar; 22(3):287.e1-9. PubMed ID: 26548508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B.
    Wang Y; Thongsawat S; Gane EJ; Liaw YF; Jia J; Hou J; Chan HL; Papatheodoridis G; Wan M; Niu J; Bao W; Trylesinski A; Naoumov NV
    J Viral Hepat; 2013 Apr; 20(4):e37-46. PubMed ID: 23490388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor development delay in offspring is associated with prenatal telbivudine exposure.
    Zhou C; Yu Y; Yang Q; Wang H; Hou M; Jin L; Zhang F; Sheng J; Miao M; Yang X; Huang HF
    Medicine (Baltimore); 2018 Mar; 97(9):e0053. PubMed ID: 29489662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic flare after telbivudine withdrawal and efficacy of postpartum antiviral therapy for pregnancies with chronic hepatitis B virus.
    Liu J; Wang J; Jin D; Qi C; Yan T; Cao F; Jin L; Tian Z; Guo D; Yuan N; Feng W; Zhang S; Zhao Y; Chen T
    J Gastroenterol Hepatol; 2017 Jan; 32(1):177-183. PubMed ID: 27161163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience.
    Tsai MC; Chen CH; Tseng PL; Hung CH; Chiu KW; Wang JH; Lu SN; Lee CM; Chang KC; Yen YH; Lin MT; Chou YP; Hu TH
    Clin Microbiol Infect; 2016 Jan; 22(1):95.e1-95.e7. PubMed ID: 26055419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.